Cleared Traditional

K172965 - Handheld VitalSigns Monitoring System

K172965 is the FDA 510(k) clearance for Handheld VitalSigns Monitoring System by Visiomed Technology Co.,Ltd. It is a Class 2 Cardiovascular device (product code MWI) cleared through the Traditional 510(k) pathway after a 447-day FDA review.

K172965 · Visiomed Technology Co.,Ltd · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
447d
Days
Class 2
Risk

K172965 is an FDA 510(k) clearance for the Handheld VitalSigns Monitoring System. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Visiomed Technology Co.,Ltd (Bao An, Shenzhen,, CN). The FDA issued a Cleared decision on December 17, 2018 after a review of 447 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Visiomed Technology Co.,Ltd devices

Submission Details

510(k) Number K172965 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 26, 2017
Decision Date December 17, 2018
Days to Decision 447 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
322d slower than avg
Panel avg: 125d · This submission: 447d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Shenzhen Joyantech Consulting Co., Ltd.
Filed Fu

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 123
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K172965.
Patient Monitor
K181919 · Guangdong Biolight Meditech Co., Ltd. · Apr 2019
3880 MRI Patient Monitoring System
K180903 · Iradimed Corporation · Mar 2019
Accutorr 7/VS-900/VS-900c Vital Signs Monitor
K182821 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Mar 2019
3880 MRI Patient Monitoring System
K182900 · Iradimed Corporation · Dec 2018
Unity Network ID
K183116 · Ge Healthcare · Dec 2018
AirStrip RPM InvisionHeart Adapter
K182226 · Airstrip Technologies, Inc. · Sep 2018